Compounds > bay n 7133
Page last updated: 2024-09-03

bay n 7133 and Candidiasis

bay n 7133 has been researched along with Candidiasis in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Plempel, M2
Lefler, E; Stevens, DA1

Other Studies

3 other study(ies) available for bay n 7133 and Candidiasis

ArticleYear
[Correlation of in vitro and in vivo actions of azole antimycotics].
    Mykosen, 1984, Volume: 27, Issue:1

    Topics: Animals; Antifungal Agents; Candidiasis; Flucytosine; In Vitro Techniques; Ketoconazole; Male; Mice; Mice, Inbred Strains; Triazoles

1984
Antimycotic activity of BAY N 7133 in animal experiments.
    The Journal of antimicrobial chemotherapy, 1984, Volume: 13, Issue:5

    Topics: Administration, Oral; Administration, Topical; Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Female; Flucytosine; Guinea Pigs; Hair; Infusions, Parenteral; Ketoconazole; Male; Mice; Mycoses; Triazoles

1984
New azole compounds: vibunazole (Bay n7133) and Bay L9139, compared with ketoconazole in the therapy of systemic candidosis and in pharmacokinetic studies, in mice.
    The Journal of antimicrobial chemotherapy, 1985, Volume: 15, Issue:1

    Topics: Animals; Antifungal Agents; Candidiasis; Imidazoles; Ketoconazole; Kinetics; Mice; Triazoles

1985